PubRank

O I Kiselev

Author PubWeight™ 25.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 DNA-polycation complexes: effect of polycation structure on physico-chemical and biological properties. J Biotechnol 2006 0.94
2 Amyloidogenic peptide homologous to beta-domain region of alpha-lactalbumin. Dokl Biochem Biophys 2007 0.89
3 Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein. Biochemistry (Mosc) 2012 0.88
4 Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein. Tuberculosis (Edinb) 2006 0.84
5 [Analysis of pandemic influenza in Russia as a part of the global process based on data of an influenza monitoring reference center]. Zh Mikrobiol Epidemiol Immunobiol 2011 0.83
6 Amplification of DNA sequences of Epstein-Barr and human immunodeficiency viruses using DNA-polymerase from Thermus thermophilus. Mol Cell Probes 1990 0.82
7 [Cowpea mosaic virus chimeric particles bearing ectodomain of matrix protein 2 (M2E) of influenza A virus: production and characteristics]. Mol Biol (Mosk) 2009 0.81
8 [The 2009 pandemic influenza in Russia. I. Diagnosis and molecular biological characteristics of the virus]. Vopr Virusol 2011 0.81
9 Atomic force microscopy study of peptides homologous to beta-domain of alpha-lactalbumins. Protein Pept Lett 2007 0.81
10 [Antiviral activity of several vasodilator agents]. Biull Eksp Biol Med 1996 0.81
11 Recombinant influenza vaccines. Acta Naturae 2012 0.80
12 DNA sequencing with thermostable Tet DNA polymerase from Thermus thermophilus. Nucleic Acids Res 1989 0.80
13 The efficacy of cell therapy in the treatment of patients with trophic venous ulcers of the lower limbs. Angiol Sosud Khir 2007 0.79
14 [Secondary structure of the M2 protein of influenza type A virus and its role in forming resistance to rimantadine and deitiforin]. Mol Biol (Mosk) 1995 0.79
15 [Molecular characteristic of influenza virus A H5N1 Strains isolated from poultry in Kurgan Region in 2005]. Mol Biol (Mosk) 2008 0.78
16 [Activation of free radicals reaction and changes in the state of antioxidant protection in blood in toxic experimental influenza infection]. Biull Eksp Biol Med 1992 0.78
17 [Universal diagnostic oligonucleotide microarray for subtyping of human and animal influenza A viruses]. Vopr Virusol 2014 0.78
18 [In vitro and in vivo effects of ingavirin on the ultrastructure and infectivity of influenza virus]. Vopr Virusol 2011 0.77
19 [Effect of different water-soluble forms of the fullerene C60 on the metabolic activity and ultra-structure of cells in culture]. Biofizika 2012 0.77
20 [Experimental study of Ingavirin antiviral activity against human adenovirus]. Antibiot Khimioter 2010 0.77
21 [Antiviral activity of Ingavirin in experimental lethal influenza due to influenza virus B in albino mice]. Antibiot Khimioter 2010 0.77
22 [Protective activity of Ingavirin in experimental lethal influenza due to pandemic influenza virus A (H1N1)v in albino mice]. Antibiot Khimioter 2010 0.77
23 Development of Recombinant Vaccine against A(H1N1) 2009 Influenza Based on Virus-like Nanoparticles Carrying the Extracellular Domain of M2 Protein. Acta Naturae 2010 0.77
24 Fatty acid acylated antibodies against virus suppress its reproduction in cells. FEBS Lett 1989 0.77
25 [Study of tolerability and reactogenicity of pandemic vaccines against influenza type A/H1N1]. Zh Mikrobiol Epidemiol Immunobiol 2010 0.77
26 [The structural and functional analysis of the biological activity of acridine derivatives]. Vestn Ross Akad Med Nauk 2004 0.76
27 [Experimental investigation of Ingavirin antiviral activity against human parainfluenza virus]. Antibiot Khimioter 2010 0.76
28 Insulin fibrillogenesis in vitro. Dokl Biochem Biophys 2008 0.76
29 [Development of the anti-influenza H5N1 vaccines worldwide and in Russia]. Zh Mikrobiol Epidemiol Immunobiol 2006 0.76
30 [Universal influenza vaccines: developments, prospects for use]. Vopr Virusol 2012 0.76
31 [Reconstruction of autonomic genetic and protein-synthesizing systems from viral RNA and isolated mitochondria]. Dokl Akad Nauk SSSR 1971 0.76
32 [Influence of rimantadine, ribavirine and triazavirine on influenza A virus replication in human monolayer and lymphoblastoid cell lines]. Antibiot Khimioter 2011 0.75
33 [Antiviral action of some antioxidants/antihypoxants and their combinations with remantadine against human influenza A(H3N2) virus studied in in vitro models]. Eksp Klin Farmakol 2007 0.75
34 [The influence of atropine blocking of the vagus nerves on the excitability of the left ventricle in the guinea pig]. Biull Eksp Biol Med 1966 0.75
35 [Ingavirin treatment of experimental parainfluenza pneumonia in Syrian hamsters]. Vopr Virusol 2012 0.75
36 [Intranasal co-administration of recombinant streptococcus group B polypeptides and influenza deltaNS1 vaccine]. Vopr Virusol 2013 0.75
37 [ANTIVIRAL ACTIVITY OF THE DIHYDROQUERCETIN DURING THE COXSACKIEVIRUS B4 REPLICATION IN VITRO]. Vopr Virusol 2016 0.75
38 [Detection of nucleotide sequences specific for retroviruses in Saccharomyces cells]. Genetika 1987 0.75
39 [The effect of influenza virus hemagglutinin on erythrocytes and thrombocytes]. Izv Akad Nauk Ser Biol 1999 0.75
40 [Interleukin-2 and cancer immunotherapy]. Vopr Onkol 1989 0.75
41 [The International Scientific Conference on the Optimization of Influenza Control]. Vopr Virusol 1994 0.75
42 [Preclinical studies of live intranasal H5N1 influenza vaccine with the deleted HS1 gene]. Vopr Virusol 2012 0.75
43 [The membranotropic and neurotropic properties of remantadine and deitiforin in experimental models]. Vopr Virusol 1991 0.75
44 [H1N1V influenza epidemic of 2009 in Russia]. Vestn Ross Akad Med Nauk 2011 0.75
45 [Genetic diversity and molecular evolution of the influenza A viruses in Russia during 2006-2012]. Vopr Virusol 2013 0.75
46 [Regulation of expression of the htpR gene in Escherichia coli]. Mol Biol (Mosk) 1987 0.75
47 [Anti-HIV activity of complex isoborneol ethers]. Dokl Akad Nauk 1992 0.75
48 [Effect of fullerene C60-polyvinilpyrrolidone complexes on influenza virus reproduction]. Vopr Virusol 2001 0.75
49 [Molecular chaperones: new proteins--new functions]. Mol Biol (Mosk) 1992 0.75
50 No-Spa and Remantadin are the novel complex preparations that inhibit effectively reproduction of the avian influenza viruses. Dokl Biol Sci 2007 0.75
51 [Immunomodulating activity of natural killers in patients with breast tumors using vasopressin and interleukin 2 in vitro]. Vopr Onkol 1989 0.75
52 [Features of interepidemic influenza A and B viruses]. Vestn Ross Akad Med Nauk 1995 0.75
53 [Synergism of processes of generating active forms of oxygen and proteolysis as a possible reason for developing influenza]. Dokl Akad Nauk SSSR 1991 0.75
54 [The effective use of superoxide dismutase from human erythrocytes in the late stages of experimental influenza infection]. Vopr Virusol 1992 0.75
55 [International symposium on military-civilian cooperation in surveillance and control of influenza]. Vopr Virusol 2004 0.75
56 [The isolation and study of the properties of current influenza A viruses (H1N1) with a natural resistance to remantadine]. Vopr Virusol 1991 0.75
57 [Studying the effect of antioxidants and/or antihypoxants on cell cultures under conditions of cytotoxic action of rimantadine]. Eksp Klin Farmakol 2007 0.75
58 [Human papilloma virus and lymphatic metastasis in squamous cell carcinoma of the cervix]. Vopr Onkol 2011 0.75
59 [Effect of homologous nuclear RNA and infectious RNA of the Venezuelan equine encephalitis virus on the biosynthesis of RNA and protein in isolated rat liver mitochondria]. Biokhimiia 1974 0.75
60 [Determination of nucleotide sequences of Russian isolates of delta hepatitis virus]. Mol Gen Mikrobiol Virusol 1997 0.75
61 [Replication of infectious viral RNA in isolated mitochondria. II. Replication of viral RNA in mitochondria and characteristics of the end product]. Vopr Virusol 1972 0.75
62 [Lymphokine-like activity in a culture of cells of the embryonal human brain and in the cerebrospinal fluid]. Fiziol Zh SSSR Im I M Sechenova 1988 0.75
63 Study of protein components of natural peptide regulators. Bull Exp Biol Med 2003 0.75
64 [Prevention of tuberculosis: current approaches to development of vaccines]. Vestn Ross Akad Med Nauk 2012 0.75
65 [Bird flu as a global biocatastrophe (editorial)]. Ter Arkh 2006 0.75
66 [Use of liposomes for vaccines design]. Vopr Virusol 2001 0.75
67 [Varying metabolic stability of messenger RNA of mitochondria from normal and regenerating liver and transplantable hepatoma]. Biokhimiia 1971 0.75
68 [The etiological structure of the morbidity from influenza and other ARDs on the territory of Russia in the season of 1997-1998]. Zh Mikrobiol Epidemiol Immunobiol 2000 0.75
69 [Characterization of cold-adapted influenza strain A/HongKong/1/68/162/35 as a potential donor of attenuation and high reproduction]. Vopr Virusol 2013 0.75
70 [Clinical trial of new inactivated influenza vaccine "Grifor"]. Zh Mikrobiol Epidemiol Immunobiol 2009 0.75
71 Identification of genetic determinants of influenza A virus resistance to adamantanes and neuraminidase inhibitors using biological microarray. Dokl Biochem Biophys 2015 0.75
72 [G-proteins have a sequence similar to ganglioside-binding hemagglutinins from the influenza virus]. Mol Biol (Mosk) 1991 0.75
73 [Pandemic influenza 2009 in Russia. Characteristics of the isolation and biological properties of viruses]. Vopr Virusol 2011 0.75
74 [Inhibiting effect of no-spa on paragrippe virus reproduction]. Biull Eksp Biol Med 1999 0.75
75 [Polyadenylic acid sequence in viral RNA]. Vopr Virusol 1976 0.75
76 [Isolation of an individual mRNA from mitochondria, its reverse transcription and characteristics of the complementary DNA]. Dokl Akad Nauk SSSR 1978 0.75
77 [Development of novel drugs against influenza virus based on synthetic and natural compounds]. Vopr Virusol 2013 0.75
78 [Transfer of nuclear RNA into isolated mitochondria]. Biokhimiia 1973 0.75
79 [Amplification of DNA sequences in Epstein-Barr virus and human immunodeficiency virus using DNA polymerase from Thermus thermophilus]. Mol Biol (Mosk) 1990 0.75
80 [The effect of oxygen free radicals on the viability of strains of Saccharomyces with various levels of expression of the metallothionein gene]. Dokl Akad Nauk SSSR 1989 0.75
81 [The role of influenza virus hemagglutinin in blood anticoagulation processes]. Vopr Virusol 1997 0.75
82 [Cell therapy in treatment of trophic ulcers of lower extremities]. Vestn Khir Im I I Grek 2006 0.75
83 [The origin of mitochondrial RNA in animal tissues. 4. Post-transcriptional RNA modification and polyribosome formation in isolated mitochondria]. Mol Biol (Mosk) 1976 0.75
84 [Comparative study of the differential susceptibility of different cell lines to pandemic H1N1v influenza viruses and avian influenza, swine influenza, and human influenza viruses]. Vopr Virusol 2012 0.75
85 [Genetic defect in ceruloplasmin synthesis in liver polyribosomes in Wilson-Konovalov disease]. Dokl Akad Nauk SSSR 1975 0.75
86 [Integration of the synthesis of mitochondrial proteins in the system of cytoplasmic and mitochondrial polyribosomes]. Dokl Akad Nauk SSSR 1974 0.75
87 [Current approaches to the treatment of severe influenza]. Vestn Ross Akad Med Nauk 1994 0.75
88 [A new antiviral drug Triazavirin: results of phase II clinical trial]. Vopr Virusol 2013 0.75
89 [An analysis of the potential areas of recombination in the hemagglutinin genes of animal influenza viruses in relation to their adaptation to a new host--man]. Vopr Virusol 1994 0.75
90 [ Influenza virus proteins modulate hemostasis in vitro and in vivo ]. Izv Akad Nauk Ser Biol 2004 0.75
91 [Effect of antiviral drugs with various mechanisms of action on morphogenesis of infection caused by extremely pathogenic influenza virus strains in animals]. Eksp Klin Farmakol 2011 0.75
92 [Immunosuppression at pregnancy and flu]. Vopr Virusol 2013 0.75
93 [Physicochemical characteristics of the products of virus-specific syntheses in isolated mitochondrial]. Dokl Akad Nauk SSSR 1973 0.75
94 [Oligomeric forms of recombinant interleukin-2]. Biokhimiia 1991 0.75
95 [Structure and antiviral activity of adamantane-containing polymer preparation]. Vopr Virusol 2003 0.75
96 [Deitiforine, an antiinfluenza chemotherapeutic]. Antibiot Khimioter 2013 0.75
97 [Molecular mechanisms of selecting influenza virus strains by signs of drug resistance]. Dokl Akad Nauk SSSR 1991 0.75
98 [Effect of Ingavirin on the ultrastructure of the morphogenesis of adenovirus infection in vivo]. Vopr Virusol 2012 0.75
99 [Evaluation of metabolic parameters in vitro as a model for testing the cytotoxicity of antiviral drugs]. Eksp Klin Farmakol 2006 0.75
100 [Electron transport chain in the isolated nuclei and nuclear membranes of the rat liver]. Biokhimiia 1974 0.75
101 [Cholinesterase activity and acetylcholine concentration during immunogenesis]. Zh Mikrobiol Epidemiol Immunobiol 1967 0.75
102 [Replication of infectious viral RNA in isolated mitochondria. 1. Penetration of vital RNA into mitochondria and its effect on mitochondrial synthesis]. Vopr Virusol 1972 0.75
103 [Usage of polymerase chain reaction in complex diagnosis of hepatitis B]. Vopr Virusol 2000 0.75
104 Origin of the mitochondrial RNA of animal tissues. 2. Hybridization with nuclear DNA. Mol Biol 1974 0.75
105 [The use of apoptosis inducers in the therapy of experimental influenza infection and preventing of chronic post-influenza lung damage]. Tsitologiia 2014 0.75
106 [Antiviral activity of Ingavirin on an animal model for experimental disseminated adenovirus infection]. Vopr Virusol 2012 0.75
107 [Molecular bases of prion diseases]. Vestn Ross Akad Med Nauk 1998 0.75
108 [The molecular mechanism of the action of antiviral preparations in the adamantane series]. Vestn Ross Akad Med Nauk 1993 0.75
109 [Isolation and cloning of gene for hepatitis delta antigen. The use of recombinant antigen for serodiagnosis of delta infection]. Mol Gen Mikrobiol Virusol 1998 0.75
110 [Long-term carriers of genomic structures of the influenza virus in the blood leukocytes of children with congenital pathology of central nervous system]. Vestn Ross Akad Med Nauk 1994 0.75
111 [Pathogenesis of severe influenza]. Vestn Ross Akad Med Nauk 1994 0.75
112 [Structure and function of matrix RNAs in living cells]. Usp Sovrem Biol 1975 0.75
113 [Compatibility of mitochondrial ribosomes with matrix RNA of nuclear origin]. Dokl Akad Nauk SSSR 1973 0.75
114 [Epizootics of "avian" influenza as the manifestation of pandemic]. Zh Mikrobiol Epidemiol Immunobiol 2006 0.75
115 [Clinical efficacy of arbidol (umifenovir) in the therapy of influenza in adults: preliminary results of the multicenter double-blind randomized placebo-controlled study ARBITR]. Ter Arkh 2015 0.75
116 [Several properties of the nucleic acide of nuclei and mitochondria from hepatoma induced by N-nitroso-N-diethylamine]. Vopr Onkol 1975 0.75
117 [Differences in the buoyant density of mitochondria from hepatoma, Krebs ascitic tumor II and normal liver]. Vopr Onkol 1975 0.75
118 [Influenza: current status and epidemiologic situation]. Vestn Ross Akad Med Nauk 1994 0.75
119 [Prognostic value of human papilloma virus DNA test in patients surgically treated for squamous cell cervical cancer]. Vopr Onkol 2012 0.75
120 [Detection in the structure of influenza viral proteins of sequences similar to vasoactive intestinal peptide]. Biull Eksp Biol Med 1991 0.75
121 [Quantitative competitive PCR--diagnostic method for monitoring cytomegalovirus infection and antiviral therapy]. Mol Biol (Mosk) 2000 0.75
122 [The origin of mitochondrial RNA in animal tissue. III. The occurrence of transcripts from highly reiterated sequences of nuclear genome in rat liver mitochondria]. Mol Biol 1976 0.75
123 [Polymorphism of current human influenza A and B virus population]. Vestn Ross Akad Med Nauk 1994 0.75
124 [Actinomycin D binding with the DNA of some transplantable tumors]. Dokl Akad Nauk SSSR 1971 0.75
125 [Transformation of eucaryotic cells with complexes of plasmid DNA and polycations]. Dokl Akad Nauk 1999 0.75
126 [Immunomorphological changes in the mouse brain after intracerebral administration of a neurotropic strain of influenza virus]. Biull Eksp Biol Med 1991 0.75
127 [Antiviral activity of fullerene (60)C complexed with poly(N-vinylpyrrolidone)]. Dokl Akad Nauk 1998 0.75
128 [Comparison of the influenza epidemics in Russia caused by the pandemic virus A(H1N1)pdm09 within the period from 2009 to 2013]. Vopr Virusol 2015 0.75
129 The origin of mitochondrial RNA of animal tissues studied by hybridization with mitochondrial DNA. Mol Biol 1973 0.75
130 [Technological approaches to development of whole-virion inactivated vaccine from recombinant strain against A/H5N1 influenza in the Republic of Kazakhstan]. Zh Mikrobiol Epidemiol Immunobiol 2012 0.75
131 [A new method of producing biologically active nanocomplexes by non-covalent conjugation of proteins with viral particles]. Bioorg Khim 2011 0.75
132 [The possibility of the circulation of vaccinal influenza A viral strains in the biosphere]. Dokl Akad Nauk SSSR 1990 0.75
133 [Molecular-biological properties of the rubella virus strains isolated in St. Petersburg]. Mol Biol (Mosk) 2012 0.75
134 [Synthesis of infectious viral ribonucleoproteins in isolated mitochondria]. Dokl Akad Nauk SSSR 1971 0.75
135 [Effect of polymer carrier origin and physical state on fullerene C60 phototoxicity in vitro]. Eksp Klin Farmakol 2011 0.75
136 [Properties of thermostable HtpR-mutant of Escherichia coli]. Mol Gen Mikrobiol Virusol 1988 0.75
137 CHRONIC HEPATITIS WITH DOUBLE B/C INFECTION: VIROLOGICAL, CLINICAL, MORPHOLOGICAL CHARACTERISTICS. Klin Med (Mosk) 2016 0.75